Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Ruochan Chen, Yangchun Xie, Xiao Zhong, Yongmin Fu, Yan Huang, Yixiang Zhen, Pinhua Pan, Haichao Wang, David L. Bartlett, Timothy R. Billiar, Michael T. Lotze, Herbert J. Zeh, III, Xue-Gong Fan, Daolin Tang, Rui Kang
Published Aug 11, 2016 · Vol. 7, No. 38 · pp. 61728-61740
David J. Duffy, Aleksandar Krstic, Thomas Schwarzl, Melinda Halasz, Kristiina Iljin, Dirk Fey, Bridget Haley, Jenny Whilde, Saija Haapa-Paananen, Vidal Fey, Matthias Fischer, Frank Westermann, Kai-Oliver Henrich, Steffen Bannert, Desmond G. Higgins, Walter Kolch
Published Aug 11, 2016 · Vol. 7, No. 37 · pp. 60310-60331
Arutha Kulasinghe, Chris Perry, Majid E. Warkiani, Tony Blick, Anthony Davies, Ken O'Byrne, Erik W. Thompson, Colleen C. Nelson, Ian Vela, Chamindie Punyadeera
Published Aug 9, 2016 · Vol. 7, No. 37 · pp. 60101-60109